Comparative Efficacy and Safety of Tapinarof 0.5% and 1% Cream Regimens for Atopic Dermatitis: A Network Meta-Analysis
Introduction: Atopic dermatitis (AD) is a chronic inflammatory skin disorder affecting quality of life. Tapinarof, a novel aryl hydrocarbon receptor (AhR) modulator, is a promising nonsteroidal treatmentbut, optimal dosing regimens remain unclear. Objectives: This network meta-analysis (NMA) comp...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Mattioli1885
2026-01-01
|
| Serie: | Dermatology Practical & Conceptual |
| Soggetti: | |
| Accesso online: | https://www.dpcj.org/index.php/dpc/article/view/6042 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|